ClinicalTrials.Veeva

Menu

Early Intervention With Therapeutic Exercise in Plantar Fasciopathy (PIPex-FP)

M

Miguel Hernández University of Elche

Status

Not yet enrolling

Conditions

Plantar Fascitis

Treatments

Drug: Standard treatment (oral analgesic/anti-inflammatory drug)
Other: Muscle strengthening

Study type

Interventional

Funder types

Other

Identifiers

NCT06394336
ProtocoloFP

Details and patient eligibility

About

The aim of this project is to evaluate the efficacy of a therapeutic exercise programme in patients with plantar fasciitis applied early and aimed at strengthening the hip and foot musculature.

Full description

All patients will be informed about the study to be carried out and will give their prior informed consent. The programme has a first part of teaching directed to patients by physiotherapists, and a second part of application at home, with a duration of 12 weeks. An experimental study will be designed with random assignment of patients with similar characteristics to two groups. The non-experimental group will receive their usual treatment (medication and recommnendations as stretching) and the experimental group will follow their usual treatment and also participate in the therapeutic programe.

Enrollment

60 estimated patients

Sex

All

Ages

18 to 120 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients with referred pain in the medial plantar area of the heel, accentuated with initial steps after a period of inactivity but also worsening after prolonged body weight bearing, of at least 3 months evolution prior to inclusion in the study.
  • Reproduction of the pain referred by the patient with palpation at the proximal insertion of the plantar fascia.

Exclusion criteria

  • Pregnancy.
  • Injection of corticoids in the area in the 6 months prior to recruitment.
  • Previous illnesses that may alter gait (central or peripheral neurological pathology, degenerative and inflammatory arthropathies, systemic illnesses).
  • Existence of concomitant foot pathology (metatarsalgia, stress fractures, neuropathies due to entrapment, tendinitis, history of foot/ankle surgery, etc.).
  • People who do not have the capacity to understand and follow an exercise programme.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

60 participants in 2 patient groups

Experimental group
Experimental group
Description:
People with PF who will receive the usual treatment (oral analgesic/anti-inflammatory drug) prescribed by the primary care physician and will also participate in the therapeutic exercise programme.
Treatment:
Other: Muscle strengthening
Non-experimental group
Active Comparator group
Description:
Individuals with PF who will receive the usual treatment (oral analgesic/anti-inflammatory drug) prescribed by the primary care physician
Treatment:
Drug: Standard treatment (oral analgesic/anti-inflammatory drug)

Trial contacts and locations

1

Loading...

Central trial contact

Javier Marco, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems